 |
Drs Jae Young Lee and Steven Petratos, first and last authors
respectively on the paper |
by Anne Crawford
Monash University researchers have developed – and patented – a small molecule that holds promise as a drug to help treat diseases affecting motor control, including Multiple Sclerosis (MS).
Led by Dr Steven Petratos, the researchers investigated the molecule, called DITPA, in a rare disorder called Allan-Herndon-Dudley syndrome (AHDS). The condition, which starts developing before birth, causes psychomotor retardation, whereby the person cannot control movement in their body and can have severe intellectual disability. It is inherited via a genetic mutation and only affects males.
